Related Experiment Video
Updated: Aug 11, 2025

Author Spotlight: Exploring Seaweed's Bioactive Compounds for Sustainable Innovations in Industries
Published on: November 21, 2023
Antimicrobial peptides derived from microalgae for combating antibiotic resistance: Current status and prospects
Reshma Ayswaria1, Jasna Vijayan2, Vinod Kumar Nathan3
1Department of Biotechnology, Mercy College, Palakkad, Kerala, India.
Microalgae are engineered as cell factories to produce antimicrobial peptides (AMPs), offering new solutions against drug-resistant pathogens. Advanced technologies like CRISPR-Cas enhance the development of these vital therapeutic molecules.
Area of Science:
- Biotechnology
- Microbiology
- Marine Biology
Background:
- Microalgae are versatile photosynthetic organisms capable of producing diverse bioactive compounds.
- Rising antibiotic resistance necessitates novel therapeutic strategies, with antimicrobial peptides (AMPs) showing significant promise.
- Microalgae-derived AMPs have potential applications in medicine, aquaculture, and the food industry.
Purpose of the Study:
- To review the spectrum of antimicrobial peptides (AMPs) produced by microalgae.
- To explore the technologies employed in generating novel and effective AMPs from microalgae.
- To highlight the therapeutic and industrial potential of microalgae-based AMPs.
Main Methods:
- Literature review of scientific publications on microalgae, bioactive compounds, and antimicrobial peptides.
- Analysis of genetic engineering and synthetic biology approaches, including CRISPR-Cas systems, for AMP production in microalgae.
- Examination of the applications and challenges associated with microalgae-derived AMPs.
Main Results:
- Microalgae synthesize a variety of AMPs with broad-spectrum activity against bacteria, fungi, and viruses.
- Genetic modification of microalgae significantly enhances the yield and diversity of novel AMPs.
- CRISPR-Cas and other advanced technologies offer powerful tools for designing and producing therapeutic AMPs.
Conclusions:
- Microalgae represent a sustainable and effective platform for the production of antimicrobial peptides.
- Engineered microalgae hold significant potential for combating antimicrobial resistance and addressing various industrial needs.
- Continued research into microalgal biotechnology will unlock new avenues for developing next-generation therapeutics.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Biological Methods for Microbial Control
Microorganisms in Medicine and Therapeutics
Development of Antibiotic Resistance
Antimicrobial Effectiveness

